<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu J</submitter><funding>the Foundation of the committee on science and technology of Tianjin</funding><funding>the Joint Scientific Research Project between Nankai University and Tianjin Union Medical Center</funding><funding>Tianjin Key Medical Discipline (Specialty) Construction Project</funding><pagination>23661</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11467296</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Etoposide is a second-line chemotherapy agent widely used for metastatic colorectal cancer. However, we discovered that etoposide treatment induced greater motility potential in four colorectal cancer cell lines. Therefore, we used microarrays to test the mRNA of these cancer cell lines to investigate the mechanisms of etoposide promoting colorectal cancer metastasis. Differentially expressed genes (DEGs) were identified by comparing the gene expression profiles in samples from etoposide-treated cells and untreated cells in all four colorectal cancer cell lines. Next, these genes went through the Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway analysis. Among the top 10 genes including the upregulated and downregulated,</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer.</pubmed_title><pmcid>PMC11467296</pmcid><funding_grant_id>TJYXZDXK-044A</funding_grant_id><funding_grant_id>20JCQNJC01870</funding_grant_id><funding_grant_id>2016rmnk002</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Zeng Q</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer.</name><description>Etoposide is a second-line chemotherapy agent widely used for metastatic colorectal cancer. However, we discovered that etoposide treatment induced greater motility potential in four colorectal cancer cell lines. Therefore, we used microarrays to test the mRNA of these cancer cell lines to investigate the mechanisms of etoposide promoting colorectal cancer metastasis. Differentially expressed genes (DEGs) were identified by comparing the gene expression profiles in samples from etoposide-treated cells and untreated cells in all four colorectal cancer cell lines. Next, these genes went through the Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway analysis. Among the top 10 genes including the upregulated and downregulated,</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-22T10:56:22.616Z</modification><creation>2025-04-05T23:45:43.258Z</creation></dates><accession>S-EPMC11467296</accession><cross_references><pubmed>39390002</pubmed><doi>10.1038/s41598-024-72674-8</doi></cross_references></HashMap>